Skip to content

Clinical Research on the Application of Nucleic Acid Testing in the Diagnosis and Treatment of Helicobacter pylori Infection

Clinical Research on the Application of Nucleic Acid Testing in the Diagnosis and Treatment of Helicobacter pylori Infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105836
Enrollment
Unknown
Registered
2025-07-11
Start date
2024-10-23
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Case group:None

Sponsors

Beijing Tsinghua Changgung Hospital, Tsinghua University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age is 18 years old or above. 2. Both the 13C-UBT (13Carbon-Urea Breath Test) and gastroscopy were completed during the same period, and the result of the 13C-UBT was 2 <= DOB <= 6.

Exclusion criteria

Exclusion criteria: 1. Patients experiencing diarrhea and/or constipation. 2. Patients who are unable to cooperate and/or with incomplete clinical information. 3. Patients who have repeated visits. 4. Patients whom the researcher deems unsuitable for participation in this clinical study. 5. Patients who have undergone gastrointestinal surgery. 6. Patients with severe gastrointestinal complications, such as pyloric obstruction and active bleeding under endoscopy. 7. Patients with other severe gastrointestinal diseases, such as Crohn's disease and ulcerative colitis. 8. Patients with severe liver and kidney diseases, severe heart and lung diseases, advanced tumors, blood and hematopoietic system diseases, or other severe or progressive systemic diseases. 9. Patients with mental disorders who are unable to cooperate. 10. Pregnant or breastfeeding women, or those planning to conceive within the next year. 11. Other patients whom the researcher deems unsuitable for participation in this clinical study.

Design outcomes

Primary

MeasureTime frame
Helicobacter pylori nucleic acid in fecal samples;13C-Urea Breath Test;Gastroscopy and histopathological results;

Secondary

MeasureTime frame
4 weeks after treatment 13C-Urea Breath Test ;1 year after treatment 13C-Urea Breath Test ;

Countries

China

Contacts

Public ContactXiuying Zhao

Beijing Tsinghua Changgung Hospital, Tsinghua University

zxya00340@btch.edu.cn+86 158 0104 2831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026